🇺🇸 FDA
Patent

US 11484573

Activin receptor type IIa variants and methods of use thereof

granted A61KA61K38/179A61K38/1796

Quick answer

US patent 11484573 (Activin receptor type IIa variants and methods of use thereof) held by Keros Therapeutics, Inc. expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Keros Therapeutics, Inc.
Grant date
Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K38/179, A61K38/1796, A61K38/18, A61K38/1825